Rita Mitra

Array ( [id] => 4129524 [patent_doc_number] => 06146847 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Stabilized transient gene expression' [patent_app_type] => 1 [patent_app_number] => 9/093449 [patent_app_country] => US [patent_app_date] => 1998-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 22680 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146847.pdf [firstpage_image] =>[orig_patent_app_number] => 093449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4097165 [patent_doc_number] => 06048726 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Inhibition of expression of interleukin-5' [patent_app_type] => 1 [patent_app_number] => 9/079839 [patent_app_country] => US [patent_app_date] => 1998-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 4972 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048726.pdf [firstpage_image] =>[orig_patent_app_number] => 079839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4124034 [patent_doc_number] => 06127171 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Cloning vector containing marker inactivation system' [patent_app_type] => 1 [patent_app_number] => 9/070842 [patent_app_country] => US [patent_app_date] => 1998-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 11774 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127171.pdf [firstpage_image] =>[orig_patent_app_number] => 070842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946094 [patent_doc_number] => 05998385 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Antisense oligonucleotide modulation of raf gene expression' [patent_app_type] => 1 [patent_app_number] => 9/064792 [patent_app_country] => US [patent_app_date] => 1998-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7740 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998385.pdf [firstpage_image] =>[orig_patent_app_number] => 064792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4421445 [patent_doc_number] => 06225291 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Rod opsin mRNA-specific ribozyme compositions and methods for the treatment of retinal diseases' [patent_app_type] => 1 [patent_app_number] => 9/063667 [patent_app_country] => US [patent_app_date] => 1998-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 10312 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225291.pdf [firstpage_image] =>[orig_patent_app_number] => 063667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4006756 [patent_doc_number] => 06005088 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Human NPIK gene' [patent_app_type] => 1 [patent_app_number] => 9/055699 [patent_app_country] => US [patent_app_date] => 1998-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 49713 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/005/06005088.pdf [firstpage_image] =>[orig_patent_app_number] => 055699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4349818 [patent_doc_number] => 06214806 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Use of nucleic acids containing unmethylated CPC dinucleotide in the treatment of LPS-associated disorders' [patent_app_type] => 1 [patent_app_number] => 9/030701 [patent_app_country] => US [patent_app_date] => 1998-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 13231 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214806.pdf [firstpage_image] =>[orig_patent_app_number] => 030701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4140792 [patent_doc_number] => 06060458 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use' [patent_app_type] => 1 [patent_app_number] => 9/023726 [patent_app_country] => US [patent_app_date] => 1998-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6117 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060458.pdf [firstpage_image] =>[orig_patent_app_number] => 023726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4184827 [patent_doc_number] => 06093555 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Amido and peptido modified enzymatic nucleic acid molecules' [patent_app_type] => 1 [patent_app_number] => 9/021695 [patent_app_country] => US [patent_app_date] => 1998-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 5085 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093555.pdf [firstpage_image] =>[orig_patent_app_number] => 021695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4153578 [patent_doc_number] => 06124271 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Method and conjugate for treating H. pylori infection' [patent_app_type] => 1 [patent_app_number] => 9/012198 [patent_app_country] => US [patent_app_date] => 1998-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 9947 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/124/06124271.pdf [firstpage_image] =>[orig_patent_app_number] => 012198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4085416 [patent_doc_number] => 06132999 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'L-threonine-producing microbacteria and a method for the production of L-threonine' [patent_app_type] => 1 [patent_app_number] => 9/010110 [patent_app_country] => US [patent_app_date] => 1998-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3056 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/132/06132999.pdf [firstpage_image] =>[orig_patent_app_number] => 010110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4170938 [patent_doc_number] => 06083699 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Method for bi-directional sequencing of nucleic acid polymers' [patent_app_type] => 1 [patent_app_number] => 9/009483 [patent_app_country] => US [patent_app_date] => 1998-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 11102 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083699.pdf [firstpage_image] =>[orig_patent_app_number] => 009483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3986010 [patent_doc_number] => 05959079 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'CREBA isoform' [patent_app_type] => 1 [patent_app_number] => 9/005970 [patent_app_country] => US [patent_app_date] => 1998-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10038 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/959/05959079.pdf [firstpage_image] =>[orig_patent_app_number] => 005970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4416481 [patent_doc_number] => 06194206 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Use of oligonucleotide telomerase inhibitors to reduce telomere length' [patent_app_type] => 1 [patent_app_number] => 8/998876 [patent_app_country] => US [patent_app_date] => 1997-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 23815 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194206.pdf [firstpage_image] =>[orig_patent_app_number] => 998876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4188805 [patent_doc_number] => 06093811 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Oligonucleotide modulation of cell adhesion' [patent_app_type] => 1 [patent_app_number] => 8/991525 [patent_app_country] => US [patent_app_date] => 1997-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 21 [patent_no_of_words] => 17476 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093811.pdf [firstpage_image] =>[orig_patent_app_number] => 991525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4139061 [patent_doc_number] => 06015894 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Oligonucleotide modulation of cell adhesion' [patent_app_type] => 1 [patent_app_number] => 8/982845 [patent_app_country] => US [patent_app_date] => 1997-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 21 [patent_no_of_words] => 17324 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015894.pdf [firstpage_image] =>[orig_patent_app_number] => 982845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994011 [patent_doc_number] => 05919773 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Antisense oligonucleotide modulation of raf gene expression' [patent_app_type] => 1 [patent_app_number] => 8/977424 [patent_app_country] => US [patent_app_date] => 1997-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8454 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919773.pdf [firstpage_image] =>[orig_patent_app_number] => 977424 [rel_patent_id] =>[rel_patent_doc_number] =>)